Bimatoprost 0.01 % for previously treated patients with open-angle glaucoma or ocular hypertension in the Korean clinical setting

被引：0
|
作者：
Michael Scott Kook
Susan Simonyi
Yong Ho Sohn
Chan Yun Kim
Ki Ho Park
机构：
[1] Asan Medical Centre,Department of Ophthalmology
[2] Allergan Singapore Pte,Department of Ophthalmology
[3] Ltd.,Department of Ophthalmology
[4] Mapletree Business City,undefined
[5] Kim’s Eye Hospital,undefined
[6] Yonsei University,undefined
[7] College of Medicine,undefined
[8] Seoul National University Hospital,undefined
来源：
Japanese Journal of Ophthalmology | 2015年 / 59卷
关键词：
Bimatoprost; Glaucoma; Hyperemia; Ocular hypertension; Prostamide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：325 / 334
页数：9
相关论文
共 50 条
  • [31] Prospective 18-Month Study of Bimatoprost Intracameral Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension in US Clinical Practice
    Mann, Eric
    Kammer, Jeffrey A.
    Sawhney, Gagan
    An, Jella
    Werts, Erica C.
    Vera, Vanessa
    Rivas, Marcos
    Lai, Hongxin
    Sonparote, Sadhana
    Craven, E. Randy
    DRUGS, 2025, 85 (03) : 397 - 414
  • [32] Patient-reported Outcomes of Bimatoprost Ocular Ring in an Open-label Extension Study in Patients with Open-angle Glaucoma or Ocular Hypertension
    Chen, Michelle Y.
    Sall, Kenneth N.
    Tepedino, Michael
    McLaurin, Eugene
    Olander, Kenneth
    Wirta, David
    Flynn, William
    Walker, Gary
    Ling, Jill
    Yang, Jingyuan
    Goodkin, Margot
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [33] An observational study of bimatoprost 0.01% in treatment-naive patients with primary open angle glaucoma or ocular hypertension: the CLEAR trial
    Nixon, Donald R.
    Simonyi, Susan
    Bhogal, Meetu
    Sigouin, Christopher S.
    Crichton, Andrew C.
    Discepola, Marino
    Hutnik, Cindy M. L.
    Yan, David B.
    CLINICAL OPHTHALMOLOGY, 2012, 6 : 2097 - 2103
  • [34] ELECTROOCULOGRAM CHANGES IN PATIENTS WITH OCULAR HYPERTENSION AND PRIMARY OPEN-ANGLE GLAUCOMA
    MEHAFFEY, L
    HOLOPIGIAN, K
    SEIPLE, W
    DOCUMENTA OPHTHALMOLOGICA, 1993, 83 (02) : 103 - 110
  • [35] Travoprost in the management of open-angle glaucoma and ocular hypertension
    Denis, Philippe
    Covert, David
    Realini, Anthony
    CLINICAL OPHTHALMOLOGY, 2007, 1 (01): : 11 - 24
  • [36] Brinzolamide/TimololIn Open-Angle Glaucoma and Ocular Hypertension
    Jamie D. Croxtall
    Lesley J. Scott
    Drugs & Aging, 2009, 26 : 437 - 446
  • [37] Pharmacotherapy Compliance in Patients with Ocular Hypertension or Primary Open-Angle Glaucoma
    Traverso, Carlo E.
    Walt, John G.
    Stern, Lee S.
    Dolgitser, Margarita
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2009, 25 (01) : 77 - 82
  • [38] Functional parameters in patients with ocular hypertension and primary open-angle glaucoma
    Salomone, Mariella
    Verboschi, Francesca
    Fragiotta, Serena
    Valente, Stefano
    Domanico, Daniela
    Spadea, Leopoldo
    Vingolo, Enzo M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [39] Late-day intraocular pressure–lowering efficacy and tolerability of travoprost 0.004% versus bimatoprost 0.01% in patients with open-angle glaucoma or ocular hypertension: a randomized trial
    Harvey B DuBiner
    Douglas A Hubatsch
    BMC Ophthalmology, 14
  • [40] CRITERIA FOR THE DIAGNOSIS OF OPEN-ANGLE GLAUCOMA AND OCULAR HYPERTENSION
    BASINSKY, SN
    LISTOPADOVA, NA
    VESTNIK OFTALMOLOGII, 1986, (04) : 66 - 67
12345